mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.23 |
5e-05 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |